Michel Burnier is an expert in Cardiology at University Hospital of Lausanne (Switzerland). As of October 2026, ScienceLeadR ranks Michel Burnier in the top 1% of experts worldwide for Hypertension. Michel Burnier has authored 855 publications, the most recent in 2026, and is an investigator in 21 clinical trials. SLR score: 2,619 (community average: 125). How the SLR is computed.

LeadR Profile

Michel Burnier University Hospital of Lausanne Switzerland
2 619 ScienceLeadR Reputation 2619
Network Map

Cardiology

Subspecialties: Hematology - Internal Medicine - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1984 - 2026

Source: PubMed

University Medical Policlinic Lausanne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 855

Citations

Citations: 76 870 1st author: 137 Last author: 189 Unique author: 74


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
A Practical Treatment Platform Version 3.0 for Using Angiotensin Receptor Blocker-Based Single-Pill Combinations in Patients With Hypertension.
PMID 42928416 — hypertension, receptors, angiotensin, multiple chronic conditions, angiotensins, angiotensin receptor antagonists, therapeutics, single-pill combination
High Blood Press Cardiovasc Prev20260
Lower 24-hour urinary 6-sulfatoxymelatonin and exploratory bile-acid and microbiome associations in adults with dyslipidemia: a prospectively enrolled cross-sectional study.
PMID 42842454 — bile, cross-sectional studies, dyslipidemias, hydroxymethylglutaryl-coa reductase inhibitors, gastrointestinal microbiome
Ann Med20260
Blood pressure and cardiovascular protection in chronic kidney disease: Things are moving in nephrology!
PMID 42678176 — kidney diseases, hypertension, blood, blood pressure, kidney, nephrology
Blood Press20260
Relative Melatonergic Status and Systemic Inflammatory, Oxidative, and Biological Aging Burden in Adults: An Exploratory Cross-Sectional Biomarker Analysis.
PMID 42649911 — melatonin, aging, oxidative stress, biomarkers, antioxidants, sex, records
Cancers (Basel)20260
A Dysbiosis-Urolithin A Depletion-Low 6-Sulfatoxymelatonin Triad as a Composite Biomarker Framework Across Age-Related Vascular and Malignant Disease States.
PMID 42450025 — cytokines, dysbiosis, hypertension, tumor necrosis factor-alpha, melatonin, neoplasms, interleukin-6, interleukin-8, oxidative stress, biomarkers, gastrointestinal microbiome
Int J Mol Sci20260

Clinical Studies 21

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Chair: 1

By phase:

N/A 8
Phase 4 7
Phase 3 4
Early Phase 1 1
Phase 2 1

By status:

Completed 18
Unknown 3

By type:

Interventional 20
Observational 1

By Monocentric/Multicentric:

monocentric 14
multicentric2to4 4
multicentric5to9 0
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 4

LeadR Networks

Main global connection map